The article from BioPharma Dive discusses AstraZeneca’s launch of a new health-tech business named Evinova. Here’s a summary of the key points:
Evinova’s Launch and Focus: Evinova, operating as a separate business within AstraZeneca, aims to optimize clinical trials for biotechnology companies, pharmaceutical firms, and contract research organizations (CROs). Its primary goal is to reduce the time and costs associated with developing new medicines.
Partnerships and Collaborations: Evinova has already established partnerships with two CROs, Parexel and Fortrea, to offer its digital health solutions to their customers. Additionally, it is collaborating with Accenture and Amazon Web Services to accelerate industry adoption and expand the global reach of its digital products.
Services Offered by Evinova: Evinova will provide three main categories of services: unified trial solutions, study design and planning, and portfolio management. These services include collecting clinical trial data through connected medical devices and sensors, using AI and machine learning for optimal trial design, and offering comprehensive portfolio management with predictive algorithms.
The creation of Evinova by AstraZeneca reflects the growing importance of digital health solutions in the pharmaceutical industry and the ongoing efforts to streamline and enhance the efficiency of drug development processes.